Cases
CourtFilingsPetition dateMore filters
Case closed Jan 13, 2020
Neogenix is on a liquidation path reflected in its Second Amended Plan of LiquidationDkt. 573; the supplied record identifies no pending hearings or later case milestone. The clinical-stage oncology company commenced chapter 11 on July 23, 2012, after an SEC inquiry into its use of unlicensed brokers for stock sales impaired its ability to raise capital and exposed it to potential shareholder rescission claims, as described in the first-day declarationDkt. 5.
Updated Sep 5, 6:34 AM ET
Final Decree
Dkt. 686 · Mar 9, 2020
Supplemental Notice of Chapter 11 Final Report and Motion for the Entry of a Final Decree and Case Closure to Add Additional Service Parties (Filed by Thomas J. McKee Jr.)
Dkt. 685 · Feb 14, 2020
Amended Certificate of Service of Thomas J. McKee Jr. re: 1) Motion for Final Decree and Case Closure; and 2) Notice of Chapter 11 Final Report and Motion for the Entry of a Final Decree and Case Closure (Filed by Thomas J. McKee Jr.)
Dkt. 684 · Feb 14, 2020
Use with MCP to query this case from your own tools.
Record as of September 6, 2026. Docket entries and dates come from the court. Nothing on this page is AI-generated.